cisplatin,atezolizumab
roche
['muc ,(-much)', 'atezo', 'cisplatin', 'imvigor130', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nct02807636', 'imvigor,11']
phiii imvigor130 final os of #1l atezo monotherapy (arm b) 15.2 mos vs chemo 13.3 mos (arm c) in #muc did not meet pre-specified primary endpoint, w/inferior orr to platinum-chemo in itt but atezo mono fares better in pd-l1+ cis-ineligible setting #gu23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope